文献速递哮喘

混合痰粒细胞纵向变化对严重哮喘肺功能的影响

Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program.
PubMed 文献 · Am J Respir Crit Care Med · 2021-01-01

基于SARP III队列,对成人严重哮喘患者进行基线及每年共3年的痰粒细胞纵向分组,比较以痰嗜酸性粒细胞<2%、≥2%或高度可变,以及痰中性粒细胞以50%为界分组后的肺功能与医疗使用情况。结果显示 predominantly <2%嗜酸性粒细胞组肺功能最佳,而≥2%嗜酸性粒细胞合并≥50%中性粒细胞组肺功能最差,高度可变嗜酸性粒细胞组医疗使用更多。

要点

  • 痰嗜酸性粒细胞持续<2%的严重哮喘患者肺功能最佳。
  • 痰嗜酸性粒细胞≥2%且中性粒细胞≥50%者肺功能损失更明显。
  • 痰嗜酸性粒细胞高度可变者第3年哮喘急性发作报告更多。

核心结论

  • 以痰嗜酸性粒细胞≥2%为主合并以中性粒细胞≥50%为主的患者肺功能损失更大。
  • 痰嗜酸性粒细胞高度可变者医疗使用更多。

研究设计与样本

  • SARP III队列研究,对成人严重哮喘患者进行基线及每年共3年的综合表型评估。
  • 将痰标本合格者按纵向痰嗜酸性粒细胞分为 predominantly <2%、predominantly ≥2%或高度可变三组,痰中性粒细胞以50%为界分为三组。

主要发现

  • predominantly <2%痰嗜酸性粒细胞组基线及3年间支气管舒张前FEV1%预计值最高(P < 0.01),FEV1/FVC比值最高(P < 0.001)。
  • 高度可变嗜酸性粒细胞组第3年报告的哮喘急性发作更多,但医疗使用无差异。
  • 纵向中性粒细胞分组间差异较少。
  • predominantly ≥2%嗜酸性粒细胞合并≥50%中性粒细胞组支气管舒张前FEV1%预计值最低(P = 0.049),低于predominantly <2%嗜酸性粒细胞合并<50%中性粒细胞组。

临床怎么用

  • 对严重哮喘患者可纵向监测痰嗜酸性粒细胞与中性粒细胞,识别肺功能损失风险较高的表型。
  • 痰嗜酸性粒细胞高度可变者需关注哮喘急性发作及医疗使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Some reports indicate longitudinal variability in sputum differential cell counts, whereas others describe stability. Highly variable sputum eosinophil percentages are associated with greater lung function loss than persistently elevated eosinophil percentages, but elevated neutrophils are linked to more severe asthma.Objectives: To examine sputum granulocyte stability or variability longitudinally and associations with important clinical characteristics.Methods: The SARP III (Severe Asthma Research Program III) cohort underwent comprehensive phenotype characterization at baseline and annually over 3 years. Adult subjects with acceptable sputum levels were assigned to one of three longitudinal sputum groups: eosinophils predominantly <2%, eosinophils predominantly ≥2%, or highly variable eosinophil percentages (>2 SDs determined from independent, repeated baseline eosinophil percentages). Subjects were similarly assigned to one of three longitudinal neutrophil groups with a 50% cut point.Measurements and Main Results: The group with predominantly <2% sputum eosinophils had the highest lung function (prebronchodilator FEV1% predicted, P < 0.01; FEV1/FVC ratio, P < 0.001) at baseline and throughout 3 years compared with other eosinophil groups. Healthcare use did not differ, although the highly variable eosinophil group reported more asthma exacerbations at Year 3. Longitudinal neutrophil groups showed few differences. However, a combination of predominantly ≥2% eosinophil and ≥50% neutrophil groups resulted in the lowest prebronchodilator FEV1% predicted (P = 0.049) compared with the combination with predominantly <2% eosinophils and<50% neutrophils.Conclusions: Subjects with predominantly ≥2% sputum eosinophils in combination with predominantly ≥50% neutrophils showed greater loss of lung function, whereas those with highly variable sputum eosinophils had greater healthcare use.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Hastie AT, Mauger DT, Denlinger LC, et al. Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2021. PMID: 33545021. doi:10.1164/rccm.202009-3713OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。